The Market Reports

Index

1 Pulmonary Drug Delivery Devices Market Overview
1.1 Product Overview and Scope of Pulmonary Drug Delivery Devices
1.2 Pulmonary Drug Delivery Devices Segment by Type
1.2.1 Global Pulmonary Drug Delivery Devices Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Dry Powder Inhaler
1.2.3 Metered Dose Inhaler
1.2.4 Nebulizer
1.3 Pulmonary Drug Delivery Devices Segment by Application
1.3.1 Global Pulmonary Drug Delivery Devices Sales Comparison by Application: (2021-2027)
1.3.2 Asthma
1.3.3 COPD
1.3.4 Cystic Fibrosis
1.3.5 Other
1.4 Global Pulmonary Drug Delivery Devices Market Size Estimates and Forecasts
1.4.1 Global Pulmonary Drug Delivery Devices Revenue 2016-2027
1.4.2 Global Pulmonary Drug Delivery Devices Sales 2016-2027
1.4.3 Pulmonary Drug Delivery Devices Market Size by Region: 2016 Versus 2021 Versus 2027

2 Pulmonary Drug Delivery Devices Market Competition by Manufacturers
2.1 Global Pulmonary Drug Delivery Devices Sales Market Share by Manufacturers (2016-2021)
2.2 Global Pulmonary Drug Delivery Devices Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Pulmonary Drug Delivery Devices Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Pulmonary Drug Delivery Devices Manufacturing Sites, Area Served, Product Type
2.5 Pulmonary Drug Delivery Devices Market Competitive Situation and Trends
2.5.1 Pulmonary Drug Delivery Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Pulmonary Drug Delivery Devices Players Market Share by Revenue
2.5.3 Global Pulmonary Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Pulmonary Drug Delivery Devices Retrospective Market Scenario by Region
3.1 Global Pulmonary Drug Delivery Devices Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Pulmonary Drug Delivery Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Pulmonary Drug Delivery Devices Market Facts & Figures by Country
3.3.1 North America Pulmonary Drug Delivery Devices Sales by Country
3.3.2 North America Pulmonary Drug Delivery Devices Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Pulmonary Drug Delivery Devices Market Facts & Figures by Country
3.4.1 Europe Pulmonary Drug Delivery Devices Sales by Country
3.4.2 Europe Pulmonary Drug Delivery Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pulmonary Drug Delivery Devices Market Facts & Figures by Region
3.5.1 Asia Pacific Pulmonary Drug Delivery Devices Sales by Region
3.5.2 Asia Pacific Pulmonary Drug Delivery Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Pulmonary Drug Delivery Devices Market Facts & Figures by Country
3.6.1 Latin America Pulmonary Drug Delivery Devices Sales by Country
3.6.2 Latin America Pulmonary Drug Delivery Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Pulmonary Drug Delivery Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa Pulmonary Drug Delivery Devices Sales by Country
3.7.2 Middle East and Africa Pulmonary Drug Delivery Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Pulmonary Drug Delivery Devices Historic Market Analysis by Type
4.1 Global Pulmonary Drug Delivery Devices Sales Market Share by Type (2016-2021)
4.2 Global Pulmonary Drug Delivery Devices Revenue Market Share by Type (2016-2021)
4.3 Global Pulmonary Drug Delivery Devices Price by Type (2016-2021)

5 Global Pulmonary Drug Delivery Devices Historic Market Analysis by Application
5.1 Global Pulmonary Drug Delivery Devices Sales Market Share by Application (2016-2021)
5.2 Global Pulmonary Drug Delivery Devices Revenue Market Share by Application (2016-2021)
5.3 Global Pulmonary Drug Delivery Devices Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Boehringer Ingelheim GmbH
6.1.1 Boehringer Ingelheim GmbH Corporation Information
6.1.2 Boehringer Ingelheim GmbH Description and Business Overview
6.1.3 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Product Portfolio
6.1.5 Boehringer Ingelheim GmbH Recent Developments/Updates
6.2 Novartis AG
6.2.1 Novartis AG Corporation Information
6.2.2 Novartis AG Description and Business Overview
6.2.3 Novartis AG Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Novartis AG Pulmonary Drug Delivery Devices Product Portfolio
6.2.5 Novartis AG Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Corporation Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.3.4 GlaxoSmithKline Pulmonary Drug Delivery Devices Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Corporation Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 AstraZeneca Pulmonary Drug Delivery Devices Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
6.5 Teva Pharmaceutical Industries
6.5.1 Teva Pharmaceutical Industries Corporation Information
6.5.2 Teva Pharmaceutical Industries Description and Business Overview
6.5.3 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Product Portfolio
6.5.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.6 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Merck Pulmonary Drug Delivery Devices Product Portfolio
6.6.5 Merck Recent Developments/Updates
6.7 MannKind
6.6.1 MannKind Corporation Information
6.6.2 MannKind Description and Business Overview
6.6.3 MannKind Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 MannKind Pulmonary Drug Delivery Devices Product Portfolio
6.7.5 MannKind Recent Developments/Updates
6.8 Bristol-Myers Squibb
6.8.1 Bristol-Myers Squibb Corporation Information
6.8.2 Bristol-Myers Squibb Description and Business Overview
6.8.3 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Product Portfolio
6.8.5 Bristol-Myers Squibb Recent Developments/Updates
6.9 Mylan N.V
6.9.1 Mylan N.V Corporation Information
6.9.2 Mylan N.V Description and Business Overview
6.9.3 Mylan N.V Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Mylan N.V Pulmonary Drug Delivery Devices Product Portfolio
6.9.5 Mylan N.V Recent Developments/Updates
6.10 Omron Corp
6.10.1 Omron Corp Corporation Information
6.10.2 Omron Corp Description and Business Overview
6.10.3 Omron Corp Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Omron Corp Pulmonary Drug Delivery Devices Product Portfolio
6.10.5 Omron Corp Recent Developments/Updates
6.11 F. Hoffmann-La Roche
6.11.1 F. Hoffmann-La Roche Corporation Information
6.11.2 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Description and Business Overview
6.11.3 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.11.4 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Product Portfolio
6.11.5 F. Hoffmann-La Roche Recent Developments/Updates
6.12 3M Healthcare
6.12.1 3M Healthcare Corporation Information
6.12.2 3M Healthcare Pulmonary Drug Delivery Devices Description and Business Overview
6.12.3 3M Healthcare Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.12.4 3M Healthcare Pulmonary Drug Delivery Devices Product Portfolio
6.12.5 3M Healthcare Recent Developments/Updates
6.13 Sunovion Pharmaceuticals
6.13.1 Sunovion Pharmaceuticals Corporation Information
6.13.2 Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Description and Business Overview
6.13.3 Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Product Portfolio
6.13.5 Sunovion Pharmaceuticals Recent Developments/Updates
6.14 Koninklijke Philips N.V
6.14.1 Koninklijke Philips N.V Corporation Information
6.14.2 Koninklijke Philips N.V Pulmonary Drug Delivery Devices Description and Business Overview
6.14.3 Koninklijke Philips N.V Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Koninklijke Philips N.V Pulmonary Drug Delivery Devices Product Portfolio
6.14.5 Koninklijke Philips N.V Recent Developments/Updates
6.15 Gerresheimer AG
6.15.1 Gerresheimer AG Corporation Information
6.15.2 Gerresheimer AG Pulmonary Drug Delivery Devices Description and Business Overview
6.15.3 Gerresheimer AG Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Gerresheimer AG Pulmonary Drug Delivery Devices Product Portfolio
6.15.5 Gerresheimer AG Recent Developments/Updates
6.16 Bespak
6.16.1 Bespak Corporation Information
6.16.2 Bespak Pulmonary Drug Delivery Devices Description and Business Overview
6.16.3 Bespak Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Bespak Pulmonary Drug Delivery Devices Product Portfolio
6.16.5 Bespak Recent Developments/Updates
6.17 AptarGroup
6.17.1 AptarGroup Corporation Information
6.17.2 AptarGroup Pulmonary Drug Delivery Devices Description and Business Overview
6.17.3 AptarGroup Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.17.4 AptarGroup Pulmonary Drug Delivery Devices Product Portfolio
6.17.5 AptarGroup Recent Developments/Updates
6.18 SHL Group
6.18.1 SHL Group Corporation Information
6.18.2 SHL Group Pulmonary Drug Delivery Devices Description and Business Overview
6.18.3 SHL Group Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.18.4 SHL Group Pulmonary Drug Delivery Devices Product Portfolio
6.18.5 SHL Group Recent Developments/Updates
6.19 Nypro Healthcare
6.19.1 Nypro Healthcare Corporation Information
6.19.2 Nypro Healthcare Pulmonary Drug Delivery Devices Description and Business Overview
6.19.3 Nypro Healthcare Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Nypro Healthcare Pulmonary Drug Delivery Devices Product Portfolio
6.19.5 Nypro Healthcare Recent Developments/Updates
6.20 Hovione
6.20.1 Hovione Corporation Information
6.20.2 Hovione Pulmonary Drug Delivery Devices Description and Business Overview
6.20.3 Hovione Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Hovione Pulmonary Drug Delivery Devices Product Portfolio
6.20.5 Hovione Recent Developments/Updates
6.21 Chiesi Farmaceutici S.P.A
6.21.1 Chiesi Farmaceutici S.P.A Corporation Information
6.21.2 Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Description and Business Overview
6.21.3 Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
6.21.4 Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Product Portfolio
6.21.5 Chiesi Farmaceutici S.P.A Recent Developments/Updates

7 Pulmonary Drug Delivery Devices Manufacturing Cost Analysis
7.1 Pulmonary Drug Delivery Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pulmonary Drug Delivery Devices
7.4 Pulmonary Drug Delivery Devices Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pulmonary Drug Delivery Devices Distributors List
8.3 Pulmonary Drug Delivery Devices Customers

9 Pulmonary Drug Delivery Devices Market Dynamics
9.1 Pulmonary Drug Delivery Devices Industry Trends
9.2 Pulmonary Drug Delivery Devices Growth Drivers
9.3 Pulmonary Drug Delivery Devices Market Challenges
9.4 Pulmonary Drug Delivery Devices Market Restraints

10 Global Market Forecast
10.1 Pulmonary Drug Delivery Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pulmonary Drug Delivery Devices by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Pulmonary Drug Delivery Devices by Type (2022-2027)
10.2 Pulmonary Drug Delivery Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pulmonary Drug Delivery Devices by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Pulmonary Drug Delivery Devices by Application (2022-2027)
10.3 Pulmonary Drug Delivery Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pulmonary Drug Delivery Devices by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Pulmonary Drug Delivery Devices by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Pulmonary Drug Delivery Devices Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Pulmonary Drug Delivery Devices Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Pulmonary Drug Delivery Devices Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Pulmonary Drug Delivery Devices Covered in This Study
Table 5. Global Pulmonary Drug Delivery Devices Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Pulmonary Drug Delivery Devices Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Pulmonary Drug Delivery Devices Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Pulmonary Drug Delivery Devices Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Pulmonary Drug Delivery Devices Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Pulmonary Drug Delivery Devices Manufacturing Sites and Area Served
Table 11. Manufacturers Pulmonary Drug Delivery Devices Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Pulmonary Drug Delivery Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pulmonary Drug Delivery Devices as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Pulmonary Drug Delivery Devices Sales by Region (2016-2021) & (K Units)
Table 16. Global Pulmonary Drug Delivery Devices Sales Market Share by Region (2016-2021)
Table 17. Global Pulmonary Drug Delivery Devices Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Pulmonary Drug Delivery Devices Sales by Country (2016-2021) & (K Units)
Table 19. North America Pulmonary Drug Delivery Devices Sales Market Share by Country (2016-2021)
Table 20. North America Pulmonary Drug Delivery Devices Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Pulmonary Drug Delivery Devices Revenue Market Share by Country (2016-2021)
Table 22. Europe Pulmonary Drug Delivery Devices Sales by Country (2016-2021) & (K Units)
Table 23. Europe Pulmonary Drug Delivery Devices Sales Market Share by Country (2016-2021)
Table 24. Europe Pulmonary Drug Delivery Devices Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Pulmonary Drug Delivery Devices Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Pulmonary Drug Delivery Devices Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Pulmonary Drug Delivery Devices Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Pulmonary Drug Delivery Devices Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Pulmonary Drug Delivery Devices Revenue Market Share by Region (2016-2021)
Table 30. Latin America Pulmonary Drug Delivery Devices Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Pulmonary Drug Delivery Devices Sales Market Share by Country (2016-2021)
Table 32. Latin America Pulmonary Drug Delivery Devices Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Pulmonary Drug Delivery Devices Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Pulmonary Drug Delivery Devices Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Pulmonary Drug Delivery Devices Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Pulmonary Drug Delivery Devices Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Pulmonary Drug Delivery Devices Revenue Market Share by Country (2016-2021)
Table 38. Global Pulmonary Drug Delivery Devices Sales (K Units) by Type (2016-2021)
Table 39. Global Pulmonary Drug Delivery Devices Sales Market Share by Type (2016-2021)
Table 40. Global Pulmonary Drug Delivery Devices Revenue (Million US$) by Type (2016-2021)
Table 41. Global Pulmonary Drug Delivery Devices Revenue Share by Type (2016-2021)
Table 42. Global Pulmonary Drug Delivery Devices Price (USD/Unit) by Type (2016-2021)
Table 43. Global Pulmonary Drug Delivery Devices Sales (K Units) by Application (2016-2021)
Table 44. Global Pulmonary Drug Delivery Devices Sales Market Share by Application (2016-2021)
Table 45. Global Pulmonary Drug Delivery Devices Revenue (Million US$) by Application (2016-2021)
Table 46. Global Pulmonary Drug Delivery Devices Revenue Share by Application (2016-2021)
Table 47. Global Pulmonary Drug Delivery Devices Price (USD/Unit) by Application (2016-2021)
Table 48. Boehringer Ingelheim GmbH Corporation Information
Table 49. Boehringer Ingelheim GmbH Description and Business Overview
Table 50. Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Product
Table 52. Boehringer Ingelheim GmbH Recent Developments/Updates
Table 53. Novartis AG Corporation Information
Table 54. Novartis AG Description and Business Overview
Table 55. Novartis AG Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Novartis AG Pulmonary Drug Delivery Devices Product
Table 57. Novartis AG Recent Developments/Updates
Table 58. GlaxoSmithKline Corporation Information
Table 59. GlaxoSmithKline Description and Business Overview
Table 60. GlaxoSmithKline Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. GlaxoSmithKline Pulmonary Drug Delivery Devices Product
Table 62. GlaxoSmithKline Recent Developments/Updates
Table 63. AstraZeneca Corporation Information
Table 64. AstraZeneca Description and Business Overview
Table 65. AstraZeneca Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. AstraZeneca Pulmonary Drug Delivery Devices Product
Table 67. AstraZeneca Recent Developments/Updates
Table 68. Teva Pharmaceutical Industries Corporation Information
Table 69. Teva Pharmaceutical Industries Description and Business Overview
Table 70. Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Product
Table 72. Teva Pharmaceutical Industries Recent Developments/Updates
Table 73. Merck Corporation Information
Table 74. Merck Description and Business Overview
Table 75. Merck Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Merck Pulmonary Drug Delivery Devices Product
Table 77. Merck Recent Developments/Updates
Table 78. MannKind Corporation Information
Table 79. MannKind Description and Business Overview
Table 80. MannKind Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. MannKind Pulmonary Drug Delivery Devices Product
Table 82. MannKind Recent Developments/Updates
Table 83. Bristol-Myers Squibb Corporation Information
Table 84. Bristol-Myers Squibb Description and Business Overview
Table 85. Bristol-Myers Squibb Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Bristol-Myers Squibb Pulmonary Drug Delivery Devices Product
Table 87. Bristol-Myers Squibb Recent Developments/Updates
Table 88. Mylan N.V Corporation Information
Table 89. Mylan N.V Description and Business Overview
Table 90. Mylan N.V Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Mylan N.V Pulmonary Drug Delivery Devices Product
Table 92. Mylan N.V Recent Developments/Updates
Table 93. Omron Corp Corporation Information
Table 94. Omron Corp Description and Business Overview
Table 95. Omron Corp Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Omron Corp Pulmonary Drug Delivery Devices Product
Table 97. Omron Corp Recent Developments/Updates
Table 98. F. Hoffmann-La Roche Corporation Information
Table 99. F. Hoffmann-La Roche Description and Business Overview
Table 100. F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Product
Table 102. F. Hoffmann-La Roche Recent Developments/Updates
Table 103. 3M Healthcare Corporation Information
Table 104. 3M Healthcare Description and Business Overview
Table 105. 3M Healthcare Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. 3M Healthcare Pulmonary Drug Delivery Devices Product
Table 107. 3M Healthcare Recent Developments/Updates
Table 108. Sunovion Pharmaceuticals Corporation Information
Table 109. Sunovion Pharmaceuticals Description and Business Overview
Table 110. Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Product
Table 112. Sunovion Pharmaceuticals Recent Developments/Updates
Table 113. Koninklijke Philips N.V Corporation Information
Table 114. Koninklijke Philips N.V Description and Business Overview
Table 115. Koninklijke Philips N.V Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Koninklijke Philips N.V Pulmonary Drug Delivery Devices Product
Table 117. Koninklijke Philips N.V Recent Developments/Updates
Table 118. Gerresheimer AG Corporation Information
Table 119. Gerresheimer AG Description and Business Overview
Table 120. Gerresheimer AG Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. Gerresheimer AG Pulmonary Drug Delivery Devices Product
Table 122. Gerresheimer AG Recent Developments/Updates
Table 123. Bespak Corporation Information
Table 124. Bespak Description and Business Overview
Table 125. Bespak Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. Bespak Pulmonary Drug Delivery Devices Product
Table 127. Bespak Recent Developments/Updates
Table 128. AptarGroup Corporation Information
Table 129. AptarGroup Description and Business Overview
Table 130. AptarGroup Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 131. AptarGroup Pulmonary Drug Delivery Devices Product
Table 132. AptarGroup Recent Developments/Updates
Table 133. SHL Group Corporation Information
Table 134. SHL Group Description and Business Overview
Table 135. SHL Group Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 136. SHL Group Pulmonary Drug Delivery Devices Product
Table 137. SHL Group Recent Developments/Updates
Table 138. Nypro Healthcare Corporation Information
Table 139. Nypro Healthcare Description and Business Overview
Table 140. Nypro Healthcare Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 141. Nypro Healthcare Pulmonary Drug Delivery Devices Product
Table 142. Nypro Healthcare Recent Developments/Updates
Table 143. Hovione Corporation Information
Table 144. Hovione Description and Business Overview
Table 145. Hovione Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 146. Hovione Pulmonary Drug Delivery Devices Product
Table 147. Hovione Recent Developments/Updates
Table 148. Chiesi Farmaceutici S.P.A Corporation Information
Table 149. Chiesi Farmaceutici S.P.A Description and Business Overview
Table 150. Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 151. Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Product
Table 152. Chiesi Farmaceutici S.P.A Recent Developments/Updates
Table 153. Production Base and Market Concentration Rate of Raw Material
Table 154. Key Suppliers of Raw Materials
Table 155. Pulmonary Drug Delivery Devices Distributors List
Table 156. Pulmonary Drug Delivery Devices Customers List
Table 157. Pulmonary Drug Delivery Devices Market Trends
Table 158. Pulmonary Drug Delivery Devices Growth Drivers
Table 159. Pulmonary Drug Delivery Devices Market Challenges
Table 160. Pulmonary Drug Delivery Devices Market Restraints
Table 161. Global Pulmonary Drug Delivery Devices Sales Forecast by Type (2022-2027) & (K Units)
Table 162. Global Pulmonary Drug Delivery Devices Sales Market Share Forecast by Type (2022-2027)
Table 163. Global Pulmonary Drug Delivery Devices Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 164. Global Pulmonary Drug Delivery Devices Revenue Market Share Forecast by Type (2022-2027)
Table 165. Global Pulmonary Drug Delivery Devices Sales Forecast by Application (2022-2027) & (K Units)
Table 166. Global Pulmonary Drug Delivery Devices Sales Market Share Forecast by Application (2022-2027)
Table 167. Global Pulmonary Drug Delivery Devices Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 168. Global Pulmonary Drug Delivery Devices Revenue Market Share Forecast by Application (2022-2027)
Table 169. Global Pulmonary Drug Delivery Devices Sales Forecast by Region (2022-2027) & (K Units)
Table 170. Global Pulmonary Drug Delivery Devices Sales Market Share Forecast by Region (2022-2027)
Table 171. Global Pulmonary Drug Delivery Devices Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 172. Global Pulmonary Drug Delivery Devices Revenue Market Share Forecast by Region (2022-2027)
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pulmonary Drug Delivery Devices
Figure 2. Global Pulmonary Drug Delivery Devices Market Share by Type in 2020 & 2027
Figure 3. Dry Powder Inhaler Product Picture
Figure 4. Metered Dose Inhaler Product Picture
Figure 5. Nebulizer Product Picture
Figure 6. Global Pulmonary Drug Delivery Devices Market Share by Application in 2020 & 2027
Figure 7. Asthma
Figure 8. COPD
Figure 9. Cystic Fibrosis
Figure 10. Other
Figure 11. Global Pulmonary Drug Delivery Devices Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Pulmonary Drug Delivery Devices Market Size 2016-2027 (US$ Million)
Figure 13. Global Pulmonary Drug Delivery Devices Sales 2016-2027 (K Units)
Figure 14. Global Pulmonary Drug Delivery Devices Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Pulmonary Drug Delivery Devices Sales Share by Manufacturers in 2020
Figure 16. Global Pulmonary Drug Delivery Devices Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Pulmonary Drug Delivery Devices Players: Market Share by Revenue in 2020
Figure 18. Pulmonary Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Pulmonary Drug Delivery Devices Sales Market Share by Region (2016-2021)
Figure 20. Global Pulmonary Drug Delivery Devices Sales Market Share by Region in 2020
Figure 21. Global Pulmonary Drug Delivery Devices Revenue Market Share by Region (2016-2021)
Figure 22. Global Pulmonary Drug Delivery Devices Revenue Market Share by Region in 2020
Figure 23. U.S. Pulmonary Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Pulmonary Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Pulmonary Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Pulmonary Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Pulmonary Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Pulmonary Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Pulmonary Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Pulmonary Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Pulmonary Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Pulmonary Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Pulmonary Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Pulmonary Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Pulmonary Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Pulmonary Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Pulmonary Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Pulmonary Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Pulmonary Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Pulmonary Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Pulmonary Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Pulmonary Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Pulmonary Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Pulmonary Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Pulmonary Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. UAE Pulmonary Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Pulmonary Drug Delivery Devices by Type (2016-2021)
Figure 48. Sales Market Share of Pulmonary Drug Delivery Devices by Application (2016-2021)
Figure 49. Sales Market Share of Pulmonary Drug Delivery Devices by Application in 2020
Figure 50. Revenue Share of Pulmonary Drug Delivery Devices by Application (2016-2021)
Figure 51. Revenue Share of Pulmonary Drug Delivery Devices by Application in 2020
Figure 52. Manufacturing Cost Structure of Pulmonary Drug Delivery Devices
Figure 53. Manufacturing Process Analysis of Pulmonary Drug Delivery Devices
Figure 54. Pulmonary Drug Delivery Devices Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed